Michigan SB1033 eliminates cost-sharing for insulin and diabetes devices in health insurance policies.
Michigan SB1033 amends the state's insurance laws to require health insurers to cover insulin and medically necessary diabetes devices without any cost-sharing for the insured. This means no deductibles, copayments, coinsurance, out-of-pocket expenses, aggregate lifetime limits, or annual limits will apply to these necessary medical supplies. The bill specifically addresses blood glucose test strips, glucometers, continuous glucometers, lancets, and insulin syringes.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.